ArticleOrphanet journal of rare diseases2025
Identification of NPR2 gene mutations affecting chondrocyte differentiation in short stature through JAK2-STAT5.
Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diagnosis of hypochondroplasia: international Delphi consensus recommendations.Nature reviews. Endocrinology · 2026Review
- Familial short stature: genetic architecture, risk stratification, and precision management.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundNatriuretic peptide receptor 2 (NPR2) is a crucial regulator of endochondral bone growth. However, patients carrying heterozygous NPR2 gene mutations exhibit a wide range of clinical phenotypes, and evidence regarding treatment efficacy is limited, with the pathogenic mechanisms not yet fully understood. Therefore, the aim of this study is to analyze and identify the clinical phenotypes, treatment outcomes, and pathogenic molecular mechanisms associated with NPR2 gene mutations.
methodsThrough exome sequencing, we sequenced NPR2 in three Chinese Han patients with short stature and validated the results in their families. Clinical characteristics, treatment follow-up analysis, protein 3D structure prediction, in vitro functional experiments, and transcriptome sequencing were used to examine the protein changes caused by the variants, their pathogenicity, and the underlying molecular mechanisms of the disease.
resultsAll three patients with NPR2 (p.R318W, p.I908T, p.R976H) gene mutations exhibited non-specific skeletal dysplasia and short stature, with good efficacy of recombinant human growth hormone (rhGH) treatment. Compared to the wild type, the protein expression level of NPR2 mutants was significantly reduced (P < 0.001), and CNP-induced cyclic guanosine monophosphate (cGMP) production was significantly decreased (P < 0.0001). Transcriptome sequencing analysis revealed that Csf2 is a key differentially expressed gene between NPR2 mutant and wild type, and also an upstream regulator of the JAK2-STAT5 pathway. Further validation via qRT-PCR and Western blot showed that NPR2 gene mutations significantly reduced Csf2 gene mRNA expression (P < 0.05), and protein expression of JAK2, p-JAK2, and p-STAT5 was significantly decreased (P < 0.05). Further analysis revealed that NPR2 gene mutations significantly affected the expression of chondrocyte differentiation markers Sox9, Col2A1, and BMP4 (P < 0.001).
conclusionOur study provides new insights into the loss of function of NPR2. NPR2 gene mutations may influence the expression and phosphorylation levels of proteins in the JAK2-STAT5 signaling pathway by downregulating Csf2, thereby affecting chondrocyte differentiation and ultimately leading to short stature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.